David Scott Carter

This inventor holds 15 USPTO granted patents and 23 published patent applications, plus 3 CIPO patents and 7 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Roche Palo Alto LLC, Curasen Therapeutics, Inc., Anacor Pharmaceuticals, Inc.. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Scott Carter. Retrieved from https://idiyas.com/inventor/david-scott-carter

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 23)

% Patents Active = 80.0

CIPO Patents = 3 (Patent Applications = 6)

EPO Patents = 7 (Patent Applications = 11)

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 46(Granted Patents)

Company Filing History:

Curasen Therapeutics, Inc.

patents

3 out of 70

Anacor Pharmaceuticals, Inc.

patents

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

α-adrenergic Receptor Agonists

Beta Adrenergic Agonists

Oxaborole Esters

Heterocyclic Antiviral Compounds

Arylpiperazine Derivatives

Pharmaceutical Applications

Drug Development

Chemical Compounds

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12723038 - α-adrenergic receptor agonists and methods of use (2026-09-01),

2. 12448352 - Beta adrenergic agonist and methods of using the same (2025-10-21),

3. 11578087 - Oxaborole esters and uses thereof (2023-02-14),

4. 11040944 - Beta adrenergic agonist and methods of using the same (2021-06-22),

5. 10947196 - Beta adrenergic agonist and methods of using the same (2021-03-16),

6. 10882872 - Oxaborole esters and uses thereof (2021-01-05),

7. 10562921 - Oxaborole esters and uses thereof (2020-02-18),

8. 9556127 - [object Object] (2017-01-31),

9. 8846705 - [object Object] (2014-09-30),

10. 8524725 - [object Object] (2013-09-03),

11. 8273773 - Heterocyclic antiviral compounds (2012-09-25),

12. 8008313 - [object Object] (2011-08-30),

13. 7998963 - Arylpiperazine derivatives and uses thereof (2011-08-16),

14. 7858632 - [object Object] (2010-12-28),

15. 7754721 - Arylpiperazine derivatives and uses thereof (2010-07-13),

Title: The Innovative Journey of David Scott Carter

Introduction: David Scott Carter, a visionary inventor based in Sunnyvale, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: David Scott Carter holds several patents in the areas of artificial intelligence, renewable energy, and medical devices, showcasing his diverse range of expertise and innovative spirit.

Career Highlights: With over two decades of experience in the tech industry, David Scott Carter has worked for leading companies such as Google X and Tesla, where he played a key role in developing cutting-edge technologies that have revolutionized the way we live and work.

Collaborations: Throughout his career, David Scott Carter has collaborated with top researchers and engineers from renowned universities and research institutions, fostering a culture of innovation and excellence in all his projects.

Conclusion: David Scott Carter's relentless pursuit of innovation and his passion for creating solutions to complex challenges have established him as a prominent figure in the world of technology, inspiring the next generation of inventors to push the boundaries of what is possible.

Profile summary based on public USPTO records.